full
border
#666666
https://www.arboretumvc.com/wp/wp-content/themes/zap-installable/
https://www.arboretumvc.com/wp/
#ffffff
style1

24
Sep

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, announced results of the company’s landmark REDUCE FMR clinical trial, which were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Diego.
Link

0 Comments
21
Sep

SI-BONE, Inc.(“SI-BONE”), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. SI-BONE has applied to list its common stock on The Nasdaq Global Market under the ticker symbol “SIBN”.
Link

0 Comments
17
Sep

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a strategic partnership to commercialize two new fully integrated systems for automation of PCR (polymerase chain reaction) testing. These next-generation systems are specifically designed to help clinical molecular diagnostic laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases.

Link

0 Comments
06
Sep

Strata Oncology, Inc. today announced it is participating as a CLIA-certified/accredited laboratory for the precision medicine cancer trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131). The objective of this ongoing phase II trial, co-led by the National Cancer Institute (NCI), part of the National Institutes of Health, and the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), is to match genetic abnormalities of tumors with suitable targeted therapy, regardless of cancer type.
Link

0 Comments
15
Aug

Aira is excited to announce that Anirudh Koul, founder of the award-winning Seeing AI app, and former Senior Data Scientist at Microsoft is joining Aira as Head of Artificial Intelligence and Research. In this role, Anirudh will lead the development of Aira’s AI platform, leveraging advances in computer vision and machine learning to improve the experience and capabilities of both Aira agents and Explorers.

Link

0 Comments
09
Aug

Investors pride themselves on being independent thinkers. There are times, however, when even some of us in the venture capital industry are guilty of running with the herd.
As a limited partner, it’s tempting to think you’ll only succeed if you invest solely in the top firms. But data suggest investors should be more adventurous.
Link

0 Comments
scrollauto
Loading posts...
link_magnifier
#ffffff
on
loading
off